Literature DB >> 9155064

Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci.

M Esteller1, A García, J M Martínez-Palones, J Xercavins, J Reventós.   

Abstract

A case-control study was designed to identify associations between polymorphisms at p53, cytochrome P-450 (CYP1A1) and glutathione-S-transferases and endometrial cancer susceptibility. Among all polymorphisms analysed, an insertional variant in p53 (P53PIN3) and two polymorphisms in the 3'-end and exon 7 of CYP1A1 showed significant association with enhanced endometrial cancer risk.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9155064      PMCID： PMC2228224          DOI： 10.1038/bjc.1997.235

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  21 in total

1.  Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene.

Authors:  S Hayashi; J Watanabe; K Nakachi; K Kawajiri
Journal:  J Biochem       Date:  1991-09       Impact factor: 3.387

2.  Simple sequence repeat polymorphism within the p53 gene.

Authors:  V Lazar; F Hazard; F Bertin; N Janin; D Bellet; B Bressac
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

Review 3.  Has the breast cancer gene been found?

Authors:  B Vogelstein; K W Kinzler
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

4.  Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism.

Authors:  S Pemble; K R Schroeder; S R Spencer; D J Meyer; E Hallier; H M Bolt; B Ketterer; J B Taylor
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

5.  Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer.

Authors:  S Zhong; A H Wyllie; D Barnes; C R Wolf; N K Spurr
Journal:  Carcinogenesis       Date:  1993-09       Impact factor: 4.944

6.  An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.

Authors:  T G Krontiris; B Devlin; D D Karp; N J Robert; N Risch
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

7.  Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.

Authors:  P G Shields; E D Bowman; A M Harrington; V T Doan; A Weston
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

8.  Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types.

Authors:  A K Alexandrie; M I Sundberg; J Seidegård; G Tornling; A Rannug
Journal:  Carcinogenesis       Date:  1994-09       Impact factor: 4.944

9.  Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship.

Authors:  J M Schildkraut; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

10.  Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer.

Authors:  T R Rebbeck; E A Rosvold; D J Duggan; J Zhang; K H Buetow
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994-09       Impact factor: 4.254
View more
  11 in total

1.  TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.

Authors:  De-Ke Jiang; Lei Yao; Wei-Hua Ren; Wen-Zhang Wang; Bo Peng; Long Yu
Journal:  Med Oncol       Date:  2010-06-15       Impact factor: 3.064

2.  Association of p53 genomic instability with the glutathione S-transferase null genotype in gastric cancer in the Portuguese population.

Authors:  A R Conde; G Martins; C Saraiva; J Rueff; C Monteiro
Journal:  Mol Pathol       Date:  1999-06

3.  GSTM1 and GSTT1 copy number variation in population-based studies of endometrial cancer risk.

Authors:  Stalo Karageorgi; Jennifer Prescott; Jason Y Y Wong; I-Min Lee; Julie E Buring; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-10       Impact factor: 4.254

4.  Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.

Authors:  Hannah P Yang; Jesus Gonzalez Bosquet; Qizhai Li; Elizabeth A Platz; Louise A Brinton; Mark E Sherman; James V Lacey; Mia M Gaudet; Laurie A Burdette; Jonine D Figueroa; Julia G Ciampa; Jolanta Lissowska; Beata Peplonska; Stephen J Chanock; Montserrat Garcia-Closas
Journal:  Carcinogenesis       Date:  2010-01-06       Impact factor: 4.944

Review 5.  Genetic polymorphisms and endometrial cancer risk.

Authors:  Larissa A Meyer; Shannon N Westin; Karen H Lu; Michael R Milam
Journal:  Expert Rev Anticancer Ther       Date:  2008-07       Impact factor: 4.512

6.  Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk.

Authors:  Min Li; Yuan-Yue Li; Xiao-Yan Xin; Ying Han; Ting-Ting Wu; Hong-Bo Wang
Journal:  Tumour Biol       Date:  2013-07-17

7.  Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer.

Authors:  Osamu Nunobiki; Masatsugu Ueda; Michiko Yamamoto; Eisaku Toji; Naomi Sato; Shinji Izuma; Yoshiaki Okamoto; Kiyo Torii; Sadamu Noda
Journal:  Hum Cell       Date:  2009-11       Impact factor: 4.174

8.  Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.

Authors:  Linxiao Han; Yanyan Liu; Weiwei Cao; Xiuying Yuan; Cuifeng Li
Journal:  Tumour Biol       Date:  2013-08-07

9.  Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection.

Authors:  Zoi Lanara; Efstathia Giannopoulou; Marta Fullen; Evangelos Kostantinopoulos; Jean-Christophe Nebel; Haralabos P Kalofonos; George P Patrinos; Cristiana Pavlidis
Journal:  Hum Genomics       Date:  2013-06-05       Impact factor: 4.639

Review 10.  Germline polymorphism of cancer susceptibility genes in gynecologic cancer.

Authors:  Masatsugu Ueda; Eisaku Toji; Osamu Nunobiki; Shinji Izuma; Yoshiaki Okamoto; Kiyo Torii; Sadamu Noda
Journal:  Hum Cell       Date:  2008-11       Impact factor: 4.374
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.